Network Pharmacology-Based Validation of Caveolin-1 as a Key Mediator of Ai Du Qing Inhibition of Drug Resistance in Breast Cancer

Network Pharmacology-Based Validation of Caveolin-1 as a Key Mediator of Ai Du Qing Inhibition of Drug Resistance in Breast Cancer

Chinese formulas have been paid increasing attention in cancer multidisciplinary therapy due to their multi-targets and multi-substances property. Here, we aim to investigate the anti-breast cancer and chemosensitizing function of Ai Du Qing (ADQ) formula made up of Hedyotis diffusa, Curcuma zedoari...

Full description

Bibliographic Details
Main Authors: Neng Wang, Bowen Yang, Xiaotong Zhang, Shengqi Wang, Yifeng Zheng, Xiong Li, Shan Liu, Hao Pan, Yingwei Li, Zhujuan Huang, Fengxue Zhang, Zhiyu Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-10-01
Series:Frontiers in Pharmacology
Subjects:
breast cancer chemosensitivity
network pharmacology
bioinformatics analysis
Ai Du Qing
caveolin-1
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2018.01106/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2018.01106/full

Similar Items